ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Myeloid YAP-HSF1 Signaling Inhibits NLRP3 Function and RIPK3-mediated Hepatocyte Necroptosis in Liver Ischemia and Reperfusion Injury

Y. Tian, D. Xu, M. Sheng, Y. Zhan, Y. Lin, C. Li, A. J. Coito, R. W. Busuttil, D. G. Farmer, J. W. Kupiec-Weglinski, B. Ke

Surgery, Dumont - UCLA Transplant Ctr, Los Angeles, CA

Meeting: 2021 American Transplant Congress

Abstract number: 613

Keywords: Immunosuppression, Inflammation, Ischemia, Liver

Topic: Basic Science » Ischemia Reperfusion & Organ Rehabilitation

Session Information

Session Name: Ischemia Reperfusion & Organ Rehabilitation

Session Type: Poster Abstract

Session Date & Time: None. Available on demand.

Location: Virtual

*Purpose: Yes-associated protein (YAP), a downstream effector of the Hippo pathway, tightly regulates cell growth, survival, and tissue inflammation. Activation of heat shock factor 1 (HSF1) has a profound impact on innate immunity during liver inflammatory response. However, it remains unknown as to whether and how the myeloid YAP-HSF1 signaling may control NLRP3 activation in sterile inflammation during liver injury. This study investigated the mechanistic link between YAP and HSF1 in the modulation NLRP3-mediated innate immune response in liver ischemia and reperfusion injury (IRI).

*Methods: Myeloid-specific YAP knockout (YAPM-KO) and floxed YAP (YAPFL/FL) mice (n=6/group) were subjected to 90 min partial liver warm ischemia followed by 6 h of reperfusion. In parallel in vitro study, bone marrow-derived macrophages (BMMs) were isolated from these conditional knockout mice and transfected with CRISPR/Cas9-mediated HSF1 knockout (KO) vector followed by LPS (100 ng/ml) stimulation.

*Results: Ischemia/reperfusion (IR) stress induced YAP and HSF1 activation evidenced by increased nuclear YAP and HSF1 expression in hepatic Kupffer cells. Myeloid YAP deficiency exacerbated IR-induced liver damage, with increased serum ALT levels, macrophage/neutrophil accumulation, and pro-inflammatory cytokine/chemokine production compared to the YAPFL/FL controls. Unlike in the YAPFL/FL controls, YAPM-KO enhanced TXNIP, RIPK3, p-MLKL, NEK7, NLRP3, ASC, cleaved caspase-1 activation in ischemic livers. However, adoptive transfer of lentivirus HSF1-modified macrophages into mice markedly improved liver function with reduced TXNIP, RIPK3, p-MLKL, and NEK7/NLRP3 but augmented TRX1 in IR-challenged livers. Moreover, disruption of RIPK3 in YAPM-KO mice with an in vivo mannose-mediated RIPK3 siRNA delivery system diminished IR-triggered hepatocyte death. In vitro studies showed that macrophage YAP and HSF1 co-localized in the nucleus whereby HSF1 interacted with YAP in response to LPS stimulation. Disruption of HSF1 with a CRISPR/Cas9 HSF1 KO transfection in YAPFL/FL macrophage augmented TXNIP and RIPK3 activation leading to enhanced NEK7/NLRP3 function and RIPK3-mediated hepatocyte necroptosis after macrophage/hepatocyte co-culture.

*Conclusions: Myeloid-specific YAP controls NLRP3-triggered liver inflammation and RIPK3-mediated hepatocyte necroptosis through interaction with HSF1. HSF1 is required for the myeloid YAP-mediated immune regulation in liver IRI. Our findings demonstrate the key mechanistic role of myeloid YAP in liver inflammatory injury, and provide novel therapeutic potential in organ IRI and transplant recipients.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Tian Y, Xu D, Sheng M, Zhan Y, Lin Y, Li C, Coito AJ, Busuttil RW, Farmer DG, Kupiec-Weglinski JW, Ke B. Myeloid YAP-HSF1 Signaling Inhibits NLRP3 Function and RIPK3-mediated Hepatocyte Necroptosis in Liver Ischemia and Reperfusion Injury [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/myeloid-yap-hsf1-signaling-inhibits-nlrp3-function-and-ripk3-mediated-hepatocyte-necroptosis-in-liver-ischemia-and-reperfusion-injury/. Accessed May 16, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences